Clinical Trials Browser

Phase 2 × INDUSTRY × racotumomab × Clear all

NCT02998983 2023-09-11

Racotumomab in Patients With High-risk Neuroblastoma

Phase 2 Completed

Neuroblastoma

NCT01240447 2014-07-10

Immunotherapy With Racotumomab Versus Support Treatment in Advanced Non-small Cell Lung Cancer Patients

Phase 2 Completed

Small Cell Lung Carcinoma